Reduced mass metformin formulations

Details for Australian Patent Application No. 2010319438 (hide)

Owner Bristol-Myers Squibb Company AstraZeneca UK Limited

Inventors Patel, Jatin M.; Abebe, Admassu; Timmins, Peter; Martin, Kyle

Agent A J Park

Pub. Number AU-A-2010319438

PCT Pub. Number WO2011/060255

Priority 61/261,049 13.11.09 US

Filing date 12 November 2010

Wipo publication date 19 May 2011

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/060255 Priority application(s): WO2011/060255

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319441-A post-mix dispenser assembly

2010319435-Bioactive fractions from stress-induced photosynthetic organisms and methods of their manufacture and use